It is widely believed that, with the passage of time, stem cells cease to differentiate between day and night cycles, in other words they lose their circadian rhythm, and that this loss promotes ag
Research Programmes / Core Facilities
Cell and Developmental Biology
Structural and Computational Biology
Chemistry and Molecular Pharmacology
Core Facilities & Services
Scientists at IRB Barcelona are supported by an extensive range of common core facilities that provide state-of-the-art technologies and scientific services. These facilities are a key asset for our research, allowing the Institute to obtain outstanding results. They are designed to incorporate the most novel technologies available and provide them to our researchers in the shortest time possible.
IRB Barcelona's partnerships, with organisations in areas of mutual interest and expertise, aim to take advantage of the wealth of knowledge, resources and technologies so critical to advancing the field of biomedicine
Selected IRB Barcelona publications
News & Events
Ageing is exacerbated by alterations of stem cell circadian rhythm
Errors made by 'DNA spellchecker’ revealed as important cause of cancer
Researchers identify the component that allows a lethal type of bacteria to spread resistance to antibiotics
CaixaImpulse funds an IRB Barcelona immunotherapy project for head and neck cancers
13SepThe multiple actions of β-Catenin along the development of the nervous system and the consequences of its deregulation
20SepOh my, what big (and new) eyes you have!
27SepDECODING THE HINDBRAIN BOUNDARIES: FROM THE GENOMIC LANDSCAPE TO THE CELLULAR FUNCTION
13NovMultidimensional Genomics: The 3D/4D organization of chromatin
Cancer is mostly caused by changes in the DNA of our cells that occur during our lifetime rather than those that we inherit from our parents.
Antibiotic resistance of the bacterium Staphylococcus aureus is responsible for 11,300 deaths a year in the United States alone—a figure that corresponds to half of all deaths caused by Gr
The third edition of the CaixaImpulse, a programme run by the Banking Foundation La Caixa and Caixa Capital Risc that supports the development of bio-health projects, is to fund an immunotherapy pr